A valuable intelligence tool for companies to support their upcoming licensing deal negotiations and their presentations to potential investors.

The database extracts solely display licensing deals for which at least one financial component (potential deal size, upfront, milestones, royalties, equity, research funding) is available. Almost 50% of the licensing deals in the database are early stage deals.

The easy to read database allows you to

Benchmark your partnering deal terms

Identify creative deal structures

Identify companies partnering in your interest area

Track competitor deal making activity

Access detailed financial information

Monitor deal trends in your areas of interest

Gain insight into how big pharma structure their licensing deals

Our customized company-company deal financials extracts are provided at a minimum of 5 and a maximum of 25 licensing deals database.

For enquiries into deal financials on specific indications, compound classes, development status at time of deal closure, territories or any other criteria of interest to you, we invite you to contact us to discuss your enquiry.